MSO and Pharmacy Synergy Generex operates an integrated MSO network paired with a growing pharmacy network via NuGenerex Distribution Solutions, presenting a cross-sell opportunity to offer outpatient clinical services, diagnostics, and DME to pharmacy customers and MSO partners.

Diagnostics and Lab Expansion With an in-house clinical diagnostic lab as part of NDS, there is potential to sell expanded testing services, personalized diagnostics, and contract lab services to partner clinics, hospitals, and disease management programs seeking faster turnaround and integrated data.

Immuno-Oncology Portfolio A legacy immune-oncology asset base provides a foundation for B2B partnerships in research collaboration, clinical trial support, and co-development opportunities with biotech and pharma companies looking to augment their oncology pipelines.

SaaS RPM Growth The NuGenHealth RPM SaaS program signals recurring revenue and a digital health footprint; cross-sell opportunities exist for patient engagement platforms, remote monitoring, and data analytics services to physicians in the MSO network.

Global COVID and Ii-Key Initiatives Past engagement with Ii-Key SARS-CoV-2 vaccine development and collaborations with Chinese CDC partners suggest potential for international partnerships, licensing, or contract manufacturing opportunities that leverage existing regulatory and development pathways.